named programs · 3 · from sources
What they call their work
Pershing Square Sohn Prize for Young Investigators in Cancer Research
Annual prize supporting early-career scientists in the New York metropolitan area pursuing innovative cancer research
Programmable Therapeutics Initiative
Funds foundational research at the Broad Institute aimed at developing next-generation medicines through programmable platforms
The MIND (Maximizing Innovation in Neuroscience Discovery) Prize
Supports pioneering neuroscience research by young investigators at leading academic institutions
activities · 4 groups
What they do
-
Genetic and Neurological Disease Research Funding 2 activities
- Awarding The MIND Prize to support innovation in neuroscience discoverySupports breakthrough neuroscience research through The MIND Prize, which funds innovative discovery projects across multiple institutions.
- Funding neuroscience research on synaptic protein degradation at The Rockefeller UniversityProvides targeted funding for research at The Rockefeller University exploring synaptic protein degradation as a therapeutic strategy for neurodegenerative diseases.
-
-
Medical Research Funding 1 activity
- Funding research on programmable therapeutics for next-generation medicinesFunds scientific research focused on programmable therapeutics to advance the development of novel, next-generation medicines.
-
-
Cancer Research Funding 1 activity
- Providing Pershing Square Sohn Prize grants to early-career cancer researchersAwards grants through the Pershing Square Sohn Prize to support high-potential, early-career scientists pursuing transformative cancer research.
-
-
General Operating Support Grants 1 activity
- Providing general operating support to AMCHAI and Citizens AllianceOffers unrestricted general operating support to organizations including AMCHAI and Citizens Alliance to strengthen their core operations.
-
financials · form 990PF · fy2024
revenue
Total revenue$36.15M
Contributions & grants——
Program service revenue——
Investment income$2.81M8%
Other revenue$34.11M
expenses
Total expenses$14.77M
Program expenses—
Admin / overhead—
Fundraising—
Salaries & benefits$410K
Grants paid out$10.93M
balance sheet
Total assets$414.59M
Cash—
Investments—
Liabilities—
Net assets$414.59M
4 years on record · 2019–2024 · YoY revenue +63.2%
leadership · form 990 part vii · fy2024
Who runs it
paid leadership · 1
| Name | Title | Hours/wk | Compensation |
|---|---|---|---|
| OLIVIA TOURNAY FLATTO | PRESIDENT | 40 | $447K |
board members · 2
- NERI OXMAN — TRUSTEE
- WILLIAM A ACKMAN — TRUSTEE
relationships · 10
Who they work with
- ALBERT EINSTEIN COLLEGE OF MEDICINE Partner — Recipient of the Pershing Square Sohn Prize for Young Investigators in Cancer Research.
- AMCHAI Partner — Received general support grant.
- CITIZENS ALLIANCE Partner — Received general support grant.
- COLD SPRING HARBOR LABORATORY Partner — Recipient of The MIND Prize for neuroscience innovation.
- CORNELL UNIVERSITY Partner — Recipient of both The MIND Prize and the Pershing Square Sohn Prize for cancer research.
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI Partner — Recipient of the Pershing Square Sohn Prize for Young Investigators in Cancer Research.
- JOHNS HOPKINS UNIVERSITY Partner — Recipient of The MIND Prize for neuroscience innovation.
- MASSACHUSETTS INSTITUTE OF TECHNOLOGY Partner — Recipient of The MIND Prize for neuroscience innovation.
- THE BROAD INSTITUTE OF MIT AND HARVARD Partner — Funded for research on programmable therapeutics.
- THE ROCKEFELLER UNIVERSITY Partner — Funded for research on synaptic protein degradation in neurodegenerative diseases.
strategies · 1
How they approach the work
Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.
- Prize-Based Research Accelerationmethodology: prize_based_research_accelerationBy offering competitive prize grants, we drive breakthroughs in high-risk scientific fields because the incentive structure attracts innovative approaches and motivates rapid progress from researchers.